Hydroxyzine is NOT Recommended as a Bridge Therapy for This 69-Year-Old Woman with Insomnia
I strongly recommend against using hydroxyzine in this older adult patient and instead suggest prescribing an FDA-approved insomnia medication such as low-dose zolpidem, eszopiclone, or suvorexant while she awaits her sleep medicine consultation.
Why Hydroxyzine Should Be Avoided
The evidence is clear that antihistamines like hydroxyzine lack systematic evidence for effectiveness in treating insomnia and carry risks that outweigh potential benefits, particularly in older adults 1. The 2005 NIH State-of-the-Science Conference on Insomnia explicitly concluded there is no systematic evidence for antihistamine effectiveness in insomnia treatment and warned that risks outweigh benefits 1.
Specific Concerns in Older Adults (Age 69):
- Increased fall risk due to anticholinergic effects and sedation
- Cognitive impairment from anticholinergic properties
- Next-day impairment affecting driving and daily function
- Limited efficacy data: Only 5 small studies (207 total patients) with mixed results 2
- No long-term safety data in older populations 2
Recommended Alternative Approach
First-Line Pharmacologic Options for Short-Term Bridge Therapy:
FDA-approved medications with evidence in older adults include:
Nonbenzodiazepine receptor agonists (zolpidem, eszopiclone, zaleplon)
Low-dose doxepin (3-6 mg)
Suvorexant or other dual orexin receptor antagonists (DORAs)
Critical Prescribing Considerations:
- Start at the lowest available dose - this is essential in a 69-year-old woman 1
- Warn about next-morning impairment and driving risks - FDA labels emphasize this concern 3
- Plan for short-term use only until sleep medicine evaluation
- Assess for fall risk, cognitive impairment, and other medications that may interact
Important Caveats
Older adults are at substantially higher risk for adverse effects from all sleep medications due to:
- Reduced drug clearance (pharmacokinetic changes)
- Increased sensitivity to peak drug effects (pharmacodynamic changes)
- 5-fold increase in memory loss, confusion, and disorientation
- 3-fold increase in dizziness, loss of balance, or falls
- 4-fold increase in residual morning sedation 3
All hypnotics are associated with serious risks including dementia, fractures, major injuries, and possibly cancer with long-term use 3. However, FDA-approved agents have better-characterized risk profiles than off-label antihistamines.
Behavioral Interventions to Initiate Immediately
While awaiting the sleep medicine appointment, implement:
- Sleep hygiene education: Fixed wake time, limit time in bed to actual sleep time, avoid daytime napping (or limit to 30 minutes before 2 PM) 1
- Stimulus control: Bedroom only for sleep and sex, leave bedroom if unable to sleep within 20 minutes 1
- Avoid sleep-fragmenting substances: Caffeine, nicotine, alcohol, especially in evening 1
The combination of FDA-approved pharmacotherapy with behavioral interventions provides better outcomes than either alone 1, with medications offering short-term relief and behavioral therapy providing sustained long-term benefit.